BIO Net Receivables vs Short Term Debt Analysis

BKYI Stock

USD 1.71 0.07 4.27%

BIO Key financial indicator trend analysis is way more than just evaluating BIO Key International prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIO Key International is a good investment. Please check the relationship between BIO Key Net Receivables and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

Net Receivables vs Short Term Debt

Net Receivables vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIO Key International Net Receivables account and Short Term Debt. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between BIO Key's Net Receivables and Short Term Debt is -0.06. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of BIO Key International, assuming nothing else is changed. The correlation between historical values of BIO Key's Net Receivables and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of BIO Key International are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Net Receivables i.e., BIO Key's Net Receivables and Short Term Debt go up and down completely randomly.

Correlation Coefficient

-0.06

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Receivables

Short Term Debt

Most indicators from BIO Key's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

The BIO Key's current Tax Provision is estimated to increase to about 128.5 K, while Selling General Administrative is projected to decrease to under 5.1 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	8.4M	13.3M	9.7M	7.5M
Cost Of Revenue	1.7M	2.0M	2.9M	1.6M

Total Operating Expenses Cost Of Revenue

BIO Key fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Non Current Liabilities Total	Other Assets
Total Assets		0.16	0.33	0.11	0.98	0.28	-0.64	-0.53	0.04	0.65	0.72	-0.31	0.64	-0.59	0.32	0.32	0.55	0.62	0.1	0.28	0.87	-0.09	-0.64	0.7	-0.37	0.37
Short Long Term Debt Total	0.16		0.06	0.2	0.13	0.05	0.33	-0.17	0.21	-0.31	0.46	-0.37	-0.31	-0.36	0.49	-0.02	0.45	0.19	0.21	0.05	-0.06	0.19	-0.29	0.43	-0.44	0.28
Other Current Liab	0.33	0.06		0.6	0.24	0.33	0.11	-0.64	0.26	-0.01	0.36	0.06	-0.01	-0.69	0.12	0.59	-0.06	0.64	0.61	0.33	0.28	0.26	-0.76	0.35	-0.35	0.49
Total Current Liabilities	0.11	0.2	0.6		-0.06	0.57	0.24	-0.7	0.78	-0.04	-0.06	-0.03	-0.03	-0.56	-0.24	0.58	-0.07	0.63	0.96	0.57	0.23	0.89	-0.59	0.19	-0.16	0.05
Total Stockholder Equity	0.98	0.13	0.24	-0.06		0.17	-0.68	-0.41	-0.1	0.65	0.75	-0.31	0.64	-0.51	0.36	0.24	0.57	0.52	-0.05	0.17	0.84	-0.25	-0.55	0.68	-0.35	0.37
Property Plant And Equipment Net	0.28	0.05	0.33	0.57	0.17		-0.36	-0.69	0.11	0.52	-0.11	-0.23	0.55	-0.5	-0.34	0.29	-0.27	0.59	0.57	1.0	0.45	0.63	-0.51	-0.15	0.11	-0.09
Net Debt	-0.64	0.33	0.11	0.24	-0.68	-0.36		0.3	0.35	-0.97	-0.1	0.14	-0.97	0.2	0.11	0.0	-0.06	-0.31	0.2	-0.36	-0.77	0.26	0.21	-0.06	0.03	0.11
Retained Earnings	-0.53	-0.17	-0.64	-0.7	-0.41	-0.69	0.3		-0.36	-0.45	-0.17	0.19	-0.45	0.87	-0.07	-0.71	0.11	-0.95	-0.73	-0.69	-0.66	-0.53	0.86	-0.25	0.43	-0.12
Accounts Payable	0.04	0.21	0.26	0.78	-0.1	0.11	0.35	-0.36		-0.22	-0.06	0.02	-0.22	-0.28	-0.02	0.36	0.26	0.34	0.67	0.11	0.09	0.66	-0.33	0.38	-0.24	-0.12
Cash	0.65	-0.31	-0.01	-0.04	0.65	0.52	-0.97	-0.45	-0.22		0.04	-0.17	1.0	-0.28	-0.2	0.13	-0.02	0.45	0.0	0.52	0.83	-0.05	-0.3	0.04	0.01	-0.14
Non Current Assets Total	0.72	0.46	0.36	-0.06	0.75	-0.11	-0.1	-0.17	-0.06	0.04		-0.24	0.03	-0.5	0.6	0.08	0.66	0.3	-0.05	-0.11	0.35	-0.29	-0.54	0.73	-0.46	0.76
Non Currrent Assets Other	-0.31	-0.37	0.06	-0.03	-0.31	-0.23	0.14	0.19	0.02	-0.17	-0.24		-0.17	0.11	-0.09	-0.19	-0.15	-0.23	-0.07	-0.23	-0.28	-0.12	0.09	-0.19	-0.2	-0.07
Cash And Short Term Investments	0.64	-0.31	-0.01	-0.03	0.64	0.55	-0.97	-0.45	-0.22	1.0	0.03	-0.17		-0.28	-0.22	0.12	-0.03	0.45	0.01	0.55	0.82	-0.03	-0.3	0.03	0.02	-0.14
Common Stock Total Equity	-0.59	-0.36	-0.69	-0.56	-0.51	-0.5	0.2	0.87	-0.28	-0.28	-0.5	0.11	-0.28		-0.37	-0.45	-0.14	-0.83	-0.56	-0.5	-0.52	-0.28	0.97	-0.46	0.72	-0.41
Common Stock Shares Outstanding	0.32	0.49	0.12	-0.24	0.36	-0.34	0.11	-0.07	-0.02	-0.2	0.6	-0.09	-0.22	-0.37		-0.05	0.44	0.1	-0.28	-0.34	0.01	-0.4	-0.33	0.55	-0.64	0.28
Inventory	0.32	-0.02	0.59	0.58	0.24	0.29	0.0	-0.71	0.36	0.13	0.08	-0.19	0.12	-0.45	-0.05		-0.17	0.8	0.66	0.29	0.52	0.46	-0.48	0.24	-0.08	0.06
Other Current Assets	0.55	0.45	-0.06	-0.07	0.57	-0.27	-0.06	0.11	0.26	-0.02	0.66	-0.15	-0.03	-0.14	0.44	-0.17		-0.01	-0.13	-0.27	0.29	-0.19	-0.17	0.86	-0.39	0.19
Other Stockholder Equity	0.62	0.19	0.64	0.63	0.52	0.59	-0.31	-0.95	0.34	0.45	0.3	-0.23	0.45	-0.83	0.1	0.8	-0.01		0.72	0.59	0.75	0.45	-0.83	0.38	-0.4	0.16
Total Liab	0.1	0.21	0.61	0.96	-0.05	0.57	0.2	-0.73	0.67	0.0	-0.05	-0.07	0.01	-0.56	-0.28	0.66	-0.13	0.72		0.57	0.29	0.86	-0.59	0.16	-0.12	0.02
Property Plant And Equipment Gross	0.28	0.05	0.33	0.57	0.17	1.0	-0.36	-0.69	0.11	0.52	-0.11	-0.23	0.55	-0.5	-0.34	0.29	-0.27	0.59	0.57		0.45	0.63	-0.51	-0.15	0.11	-0.09
Total Current Assets	0.87	-0.06	0.28	0.23	0.84	0.45	-0.77	-0.66	0.09	0.83	0.35	-0.28	0.82	-0.52	0.01	0.52	0.29	0.75	0.29	0.45		0.1	-0.55	0.49	-0.21	0.01
Short Term Debt	-0.09	0.19	0.26	0.89	-0.25	0.63	0.26	-0.53	0.66	-0.05	-0.29	-0.12	-0.03	-0.28	-0.4	0.46	-0.19	0.45	0.86	0.63	0.1		-0.28	-0.06	0.15	-0.19
Common Stock	-0.64	-0.29	-0.76	-0.59	-0.55	-0.51	0.21	0.86	-0.33	-0.3	-0.54	0.09	-0.3	0.97	-0.33	-0.48	-0.17	-0.83	-0.59	-0.51	-0.55	-0.28		-0.48	0.64	-0.45
Net Receivables	0.7	0.43	0.35	0.19	0.68	-0.15	-0.06	-0.25	0.38	0.04	0.73	-0.19	0.03	-0.46	0.55	0.24	0.86	0.38	0.16	-0.15	0.49	-0.06	-0.48		-0.54	0.28
Non Current Liabilities Total	-0.37	-0.44	-0.35	-0.16	-0.35	0.11	0.03	0.43	-0.24	0.01	-0.46	-0.2	0.02	0.72	-0.64	-0.08	-0.39	-0.4	-0.12	0.11	-0.21	0.15	0.64	-0.54		-0.32
Other Assets	0.37	0.28	0.49	0.05	0.37	-0.09	0.11	-0.12	-0.12	-0.14	0.76	-0.07	-0.14	-0.41	0.28	0.06	0.19	0.16	0.02	-0.09	0.01	-0.19	-0.45	0.28	-0.32

Click cells to compare fundamentals

BIO Key Account Relationship Matchups

BIO Key fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.5M	22.5M	17.8M	11.9M	13.7M	10.2M
Other Current Liab	686.9K	508.5K	865.6K	1.0M	908.2K	968.8K
Total Current Liabilities	4.4M	1.9M	2.0M	4.6M	4.2M	3.1M
Total Stockholder Equity	(2.3M)	20.3M	15.6M	7.1M	8.1M	8.5M
Property Plant And Equipment Net	662.0K	569.1K	323.3K	304.8K	350.5K	224.3K
Net Debt	2.7M	(16.3M)	(7.5M)	(414.1K)	(372.7K)	(354.0K)
Retained Earnings	(89.7M)	(99.5M)	(104.6M)	(114.8M)	(103.3M)	(98.2M)
Accounts Payable	919.3K	244.2K	427.8K	1.1M	1.3M	638.2K
Cash	79.0K	17.0M	7.8M	2.6M	3.0M	2.0M
Non Current Assets Total	1.1M	3.6M	3.8M	2.5M	2.9M	5.2M
Non Currrent Assets Other	240.2K	174.0K	370.7K	437.8K	503.4K	478.3K
Cash And Short Term Investments	591.8K	17.5M	7.8M	2.6M	3.0M	2.1M
Common Stock Total Equity	769.0	1.4K	1.4K	782.0	703.8	668.61
Common Stock Shares Outstanding	98.8K	261.2K	432.9K	450.0K	504.5K	388.8K
Liabilities And Stockholders Equity	2.5M	22.5M	17.8M	11.9M	13.7M	10.2M
Inventory	429.1K	330.9K	4.9M	4.8M	5.6M	5.8M
Other Current Assets	108.4K	201.5K	216.0K	327.0K	376.1K	357.3K
Other Stockholder Equity	87.4M	119.8M	120.2M	122.1M	140.4M	147.4M
Total Liab	4.8M	2.2M	2.2M	4.9M	4.4M	4.8M
Property Plant And Equipment Gross	662.0K	569.1K	323.3K	304.8K	350.5K	224.3K
Total Current Assets	1.4M	18.9M	14.0M	9.4M	10.8M	11.3M
Short Term Debt	2.4M	466.3K	177.2K	2.1M	1.9M	1.0M
Common Stock	1.4K	782.0	786.0	919.0	827.1	785.75
Net Receivables	236.9K	903.5K	1.1M	1.6M	1.8M	1.6M
Non Current Liabilities Total	390.5K	309.2K	154.3K	210.0K	189.0K	179.5K
Accumulated Other Comprehensive Income	(690.5K)	(772.3K)	0.0	(242.6K)	(218.3K)	(229.3K)
Other Assets	327.9K	240.2K	174.0K	370.7K	333.7K	317.0K
Property Plant Equipment	148.6K	662.0K	569.1K	323.3K	371.8K	240.4K
Current Deferred Revenue	359.2K	657.3K	565.4K	462.4K	416.2K	395.4K
Intangible Assets	228.2K	1.6M	1.3M	1.8M	1.6M	2.7M
Deferred Long Term Liab	319.2K	231.5K	165.3K	249.0K	286.4K	248.3K
Net Tangible Assets	3.5M	(2.5M)	17.5M	13.0M	14.9M	15.7M
Capital Surpluse	80.8M	85.6M	87.4M	119.8M	137.8M	88.3M
Net Invested Capital	(29.7K)	20.6M	15.6M	9.1M	10.4M	12.7M

Currently Active Assets on Macroaxis

C	Citigroup
CRM	Salesforce
MSFT	Microsoft
V	Visa Class A
GOOG	Alphabet Inc Class C

When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:

How To Invest In BIO

Details

Is BIO Stock a good investment?

Details

What is BIO Key's Net Worth?

Details

Largest Systems Software Companies

View

Largest Security & Protection Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for BIO Stock analysis

When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.

	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope

Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(19.62)

Revenue Per Share

17.484

Quarterly Revenue Growth

0.323

Return On Assets

(0.27)

Return On Equity

(1.26)

The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BIO Net Receivables vs Short Term Debt Analysis

Net Receivables vs Short Term Debt

Net Receivables vs Short Term Debt Correlation Analysis

Correlation Coefficient

Net Receivables

Short Term Debt

BIO Key fundamental ratios Correlations

BIO Key Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BIO Key fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for BIO Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.98	Total Assets
Common Stock	+ 0.97	Common Stock Total Equity
Total Liab	+ 0.96	Total Current Liabilities
Short Term Debt	+ 0.89	Total Current Liabilities

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock	- 0.83	Other Stockholder Equity
Other Stockholder Equity	- 0.83	Common Stock Total Equity
Total Current Assets	- 0.77	Net Debt